Clinical-pathological correlations of pituitary tumours

Bailliere's Clinical Endocrinology and Metabolism

Volumn 9, Issue 2, 1995, Pages 243-270

  Thapar, Kamal ^a   Kovacs, Kalman ^a   Muller, Paul J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLYCOPROTEIN; GONADOTROPIN; GROWTH HORMONE; PROLACTIN; THYROTROPIN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER INVASION; CARCINOGENESIS; CARCINOMA; CLINICAL FEATURE; CORTICOTROPIN RELEASE; ELECTRON MICROSCOPY; ENDOCRINE FUNCTION; GONADOTROPIN RELEASE; GROWTH HORMONE RELEASE; HISTOLOGY; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; NONHUMAN; NULL CELL; ONCOCYTOMA; PROLACTINOMA; REVIEW; THYROTROPIN RELEASE; TRANSGENIC ANIMAL; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOMA; ANIMAL; CELL DIVISION; HORMONES; HUMAN; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 0029075250     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(95)80322-X     Document Type: Article

References (79)

1. Protein kinase C activity and expression in normal and adenomatous human pituitaries
2. Invasive human pituitary tumors express a point mutated alpha-protein kinase-C
3. DNA ploidy and cell phase in human pituitary tumors
4. Neuroepithelial carcinomas in mice transgenic with human papilloma virus type 16 E6/E7 ORFs
5. Clinically nonfunctioning human pituitary adenomas
6. Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas
7. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone
8. Human pituitary null cell adenomas and oncocytomas in vitro: Effects of adenohypophysiotropic hormone and gonadal steroids on hormone secretion and tumor cell morphology
9. Pituitary hyperplasia induced by ectopic expression of nerve growth factor.
10. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series
11. Ras mutations in human prolactinomas and pituitary carcinomas
12. Surgical treatment of pituitary adenomas
13. Nonoperative management of prolactin-secreting pituitary adenomas
14. Experimental production of oestrin of pituitary tumours with hypopituitarism
15. The retinoblastoma gene in human pituitary tumors
16. Flow cytometric analysis of pituitary tumors: Correlations of nuclear antigen p105 and DNA content with clinical behavior
17. The pathophysiology of pituitaries and their tumors: Methodological advances
18. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
19. Towards selective pharmacological modulation of protein kinase C
20. Thyrotropin-secreting pituitary adenomas
21. Transgenic mice that develop pituitary tumors
22. The adenohypophysis
23. Silent corticotroph adenomas of the human pituitary gland: A histologic, immunocytologic and ultrastructural study
24. A novel type of pituitary adenoma: morphological features and clinical correlations
25. Vasoactive intestinal peptide in the human pituitary gland and adenomas
26. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence
27. Immunolocalization of cytokeratins in the normal and neoplastic human pituitary gland
28. Effects of an Rb mutation in the mouse
29. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas
30. DNA aneuploidy in adenomas of endocrine organs
31. Ras mutations in human pituitary tumors
32. Proliferation activity in pituitary adenomas: Measurement by monoclonal antibody Ki-67
33. Pathology of growth hormone excess
34. Tumors of the pituitary gland
35. Identification of corticotrophs in the human pituitary with mAB lu5, a novel immunocytochemical marker
36. Pituitary cells producing more than one hormone
37. Silent somatotroph adenomas of the human pituitary
38. Null cell adenomas of the pituitary: Attempts to resolve their cytogenesis
39. Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration: A morphologic study
40. Growth, cell proliferation, and prognosis of pituitary adenomas
41. Neurosurgical management of acromegaly
42. Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas
43. Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice
44. S-100 protein immunopositivity in human nontumorous hypophyses and pituitary adenomas
45. Ubiquitin immunoreactivity in corticotrophs following glucocorticoid treatment and in pituitary adenomas
46. Dramatic Pituitary Hyperplasia in Transgenic Mice Expressing a Human Growth Hormone-Releasing Factor Gene
47. Subclinical adenomas of the human pituitary
48. Surgical treatment of thyrotropinsecreting pituitary adenomas
49. Pituitary tumors secreting growth hormone and prolactin
50. Modal DNA content of human intracranial neoplasms studied by flow cytometry
51. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary
52. The proliferative potential of human pituitary tumors in situ
53. Novel clinical features of the growth hormone-prolactin tumor in acromegaly
54. Immunohistochemical expression of PIT-1 protein in pituitary gland of human GRF transgenic mice: its relationship with hormonal expression
55. H-ras mutation in human pituitary carcinoma metastases
56. Invasive pituitary adenomas and pituitary carcinomas
57. Estrogen receptors in human pituitary adenomas
58. Molecular pathology of sporadic pituitary tumors
59. Presence of renin, angiotensinogen and converting enzyme in human lactotroph cells and prolactin adenomas
60. Growth hormone releasing hormone (GRH) producing tumors: clinical, biochemical, and morphologic manifestation
61. Pituitary gland in hypothyroidism
62. Pathology of invasive pituitary adenomas with special reference to functional classification
63. Plurihormonal pituitary adenomas
64. Effects of estrogen on the human pituitary: A clinicopathologic study
65. The occurrence of dual invasion in pituitary adenomas
66. Immunocytochemical localization of synaptophysin in human hypophyses and pituitary adenomas
67. Argyrophilic organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary
68. Adenohypophysial changes in mice transgenic for growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation
69. Morphology of adenohypophysial tumors in mice transgenic for vasopressin-SV40 hybrid oncogene
70. In situ hybridization of estrogen receptor mRNA in human adenohypophysial cells and pituitary adenomas
71. Pituitary adenomas: Recent advances in classification, histopathology and molecular biology
72. Plurihormonal pituitary tumors: beyond the one cell-one hormone theory
73. The anterior pituitary
74. Prolactinomas: Operative management
75. Presence of glananin-like immunoreactivity in nontumorous corticotrophs and corticotroph adenomas of the human pituitary
76. Cell lines of the pituitary gonadotroph lineage derived by targeted oncogenesis in transgenic mice
77. Growth hormone-producing pituitary adenomas: Correlations between clinical characteristics and morphology
78. Human pituitary adenomas show a loss of heterozygosity at the retinoblastoma gene locus
79. Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells